UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
FDA Recall #D-0166-2025 — Class II — November 14, 2024
Product Description
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Reason for Recall
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Recalling Firm
MXBBB — El Paso, TX
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
321 bottles
Distribution
Product was sold via Amazon Marketplace.
Code Information
Lot#: 24183, Exp 07/01/28
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated